Alzhéimer

These ‘glutamatergic astrocytes’ could play a role in understanding disorders such as Alzheimer’s, according to the scientists who have discovered them

From Phoenix to Kansas City, Missouri, airports have incorporated special lanyards, a quiet room and even a simulation center where caretakers and those with dementia can learn about flying or get a refresher

The federal coverage program mainly for people ages 65 and older announced last month that it will cover Leqembi shortly after the FDA gave the treatment full approval

Yvonne Greenstreet, CEO of Alnylam Pharmaceuticals, believes we are facing a new generation of drugs that will write ‘new chapters in medicine textbooks’

These exceptional individuals maintain strong social bonds, a sense of purpose and have unique genetics that protect against dementia

In a conversation with EL PAÍS, the Indo-American doctor and writer reflects on the future of cancer treatment, as well as on the advances that have been made in the fight against Alzheimer’s and Parkinson’s

Patients given monthly infusions of Eli Lilly and Co.’s donanemab declined about four to seven months more slowly than those given dummy infusions in a large study

This thriving industry — which aims to reverse or delay age-related disease — will be worth around $610 billion globally by 2025

The decision means that the treatment, which modestly slows down the advance of the brain-robbing disease, should be covered under the U.S. health insurance program

Jackson was one of the biggest British stars of the 1960s and 70s, and won two Academy Awards, for ‘Women in Love’ in 1971 and ‘A Touch of Class’ in 1974

The decision carries extra significance because insurers have held off on paying for the drug, Leqembi, until it has full FDA approval

A rare genetic mutation protected a Colombian man from developing the hereditary dementia for two decades. The finding may open the door to new treatments for the disease

A study in monkeys and human patients shows how the blood-brain barrier can be crossed to allow the delivery of drugs that, in theory, could treat Parkinson’s and Alzheimer’s

A new study on lecanemab and other similar drugs reveals a volume reduction of unknown consequences that experts are divided about

Scientists hope that that by mimicking what protects those who dodge the gene they might one day help more common old-age Alzheimer’s

Other audience award winners included ‘The Persian Version,’ ‘Beyond Utopia’ and ‘Shayda’

In several states, compounds in hallucinogenic mushrooms are being used to treat Parkinson’s, bipolar disorder, chronic pain and other diseases

While some risk factors are out of our control, there are some things we can do to lower the likelihood of the condition

Devices enable patients to live more independently but also raise privacy concerns